The global centrifuge market size was valued at USD 508.88 million in 2025 and is projected to grow from USD 531.78 million in 2026 to USD 756.24 million by 2034, registering a CAGR of 4.5% during the forecast period from 2026 to 2034. North America dominated the centrifuge market with a market share of 37.2% in 2025.
A centrifuge is a laboratory instrument used to separate components of a mixture based on their densities by spinning the mixture at high velocities. This process generates centrifugal force, which induces denser substances to migrate to the bottom of the container while less dense substances remain closer to the top. Centrifuges are frequently employed in various scientific and medical applications, such as the separation of blood components, the isolation of proteins, and the purification of cells.
Download a Free Sample To learn more about this report,
Single-Use Centrifugation for Biopharmaceutical Processing
The centrifuge market analysis shows that the need for flexible and contamination-controlled biopharmaceutical manufacturing is creating demand for single-use centrifugation systems that reduce cleaning, sterilization, and changeover requirements. The transition toward disposable fluid-contact components allows centrifuges to support multiproduct facilities with lower cross-contamination risks and faster equipment turnaround. A 2026 study published in Biotechnology Progress demonstrated a single-use disk-stack continuous centrifuge for monoclonal-antibody harvest at volumes of up to 5,000 liters, with comparable downstream purification performance to conventional centrifugation.
AI-Enabled Centrifuge Process Optimization
The need for higher equipment reliability and consistent separation quality is driving the integration of AI, machine learning, sensors, and real-time condition monitoring into centrifuge operations. The transition toward data-driven centrifuge control enables continuous analysis of vibration, torque, temperature, feed conditions, and other operating parameters to identify abnormal conditions and optimize maintenance decisions. A 2026 study on mining centrifuges reported that an XGBoost model achieved 99.80% accuracy in predictive-maintenance analysis using centrifuge sensor data, demonstrating the potential of AI-based monitoring to reduce unexpected failures and improve equipment utilization.
Expansion of Pharmaceutical and Vaccine Manufacturing and Demand for High-Purity Separation in Specialty Chemicals Drive Market
The expansion of pharmaceutical, vaccine, and biologics manufacturing creates demand for centrifuges used in cell harvesting, clarification, plasma separation, and API processing. Higher production volumes require separation equipment capable of handling larger batches while maintaining product purity and recovery rates. Biopharmaceutical facilities, for example, use centrifuges to separate harvested cells and cellular debris from fermentation broths before downstream purification. This broader manufacturing capacity supports demand for laboratory and industrial centrifuges across upstream and downstream processing operations.
The need for high-purity chemical products creates demand for centrifuges that separate fine solids, crystals, and liquids with controlled recovery and low product loss. Specialty chemical producers use centrifugal separation for crystal recovery, catalyst separation, solvent clarification, and removal of suspended particles. Production requirements for purity-sensitive materials also increase demand for centrifuge configurations capable of handling corrosive chemicals and high-solids feed streams. These application requirements expand demand for specialized separation equipment and encourage suppliers to offer application-specific centrifuge designs.
High Initial Equipment and Installation Costs and Stringent Safety and Regulatory Requirements Restrain Market Expansion
High upfront costs for centrifuge equipment, facility integration, auxiliary systems, and installation can restrict adoption, particularly among smaller laboratories and processing facilities. Complex industrial and pharmaceutical centrifuges may also require customized configurations and supporting infrastructure, increasing the total investment required before operations begin. These capital requirements can extend purchasing cycles and limit replacement or capacity-expansion projects, slowing centrifuge market adoption.
Stringent safety, validation, calibration, cleaning, and process-control requirements can increase the complexity of centrifuge deployment in pharmaceutical, biotechnology, and medical applications. FDA guidance requires centrifuges used in biological manufacturing to undergo appropriate equipment qualification, regular calibration, rotor inspection, and validated cleaning procedures. These compliance requirements increase implementation and operating burdens, which can delay equipment adoption and restrict market expansion in highly regulated applications.
Centrifuges for Microalgae and Biofuel Processing and Centrifugal Separation for Resource-Recovery Applications Offers Growth Opportunities
Microalgae producers, biofuel manufacturers, and biorefinery operators represent potential customers for centrifuges used in biomass harvesting, dewatering, and fuel-production processes. Alfa Laval, for example, supplies decanter centrifuges specifically for ethanol and biofuel processing, with more than 400 SG2 units installed. This application creates revenue avenues through specialized centrifuge systems, installation, servicing, and process-optimization solutions, contributing to centrifuge market growth.
Municipal wastewater plants, industrial wastewater operators, biogas facilities, and circular-economy projects represent customers for centrifuges used in sludge dewatering and resource recovery. Alfa Laval offers centrifuge-based solutions for recovering value from waste streams while reducing sludge volume, disposal costs, and resource consumption. This application opens revenue opportunities through equipment sales, system integration, replacement parts, maintenance, and long-term service contracts.
Variable Feed Characteristics and Process Consistency and Shortage of Specialized Maintenance Expertise Hinders Growth
Variable particle size, solids concentration, viscosity, and temperature across industrial feed streams can make centrifuge performance difficult to maintain consistently. Operators may need repeated adjustments to throughput, differential speed, and process conditions, which reduces operational efficiency and makes equipment selection more application-specific. This variability can limit standardized deployments and make customers more cautious about expanding centrifuge capacity.
Limited access to technicians with expertise in rotor inspection, balancing, vibration analysis, and high-speed equipment servicing can make reliable centrifuge operation difficult. Beckman Coulter, for example, provides certified rotor inspection and repair services because rotor deterioration and damage can affect centrifuge operation and safety. This dependence on specialized service expertise can increase downtime and restrict utilization, particularly where local technical support networks are limited.
The refrigerated centrifuge accounted for a market share of 21.8% in 2025 due to its ability to maintain temperature-sensitive samples during high-speed separation, making it widely used in clinical diagnostics, biopharmaceutical processing, and research laboratories. Microcentrifuge benefits from widespread use in molecular biology, genomics, and clinical laboratories for rapid separation of small-volume samples. Preparative ultracentrifuges support applications in protein purification, virus isolation, organelle separation, and research activities requiring high-speed sample processing. Others cover specialized centrifugation equipment used across research, diagnostic, and industrial laboratory applications.
The analytical ultracentrifuges segment is expected to grow at a CAGR of 7.7% during the forecast period, driven by its ability to characterize biomolecules, nanoparticles, and macromolecular interactions with high analytical precision across advanced research applications. Sedimentation centrifuges support applications requiring particle separation based on density differences across laboratory, chemical, and industrial processes. Filtering centrifuges benefit from solid-liquid separation requirements across pharmaceutical, chemical, food processing, and industrial applications.
Request Customizationto receive a tailored report.
The clinical diagnostic segment accounted for a market share of 43.7% in 2025 owing to the extensive use of centrifugation for separating blood, serum, plasma, urine, and other specimens before laboratory testing and disease diagnosis. Research and Development: Research and Development benefits from the use of centrifuges for sample preparation, cell separation, protein purification, and laboratory investigations across biotechnology, pharmaceutical, and academic research.
The biotherapeutic manufacturing segment is expected to grow at a CAGR of 7.8% during the forecast period, fueled by the expansion of biologics production and the need for efficient cell harvesting, clarification, and separation during biopharmaceutical processing.
The clinical and pathology laboratories accounted for a market share of 39.6% in 2025, supported by the routine processing of patient specimens, high testing volumes, and the need for reliable separation of blood and other biological samples before diagnostic analysis. Academic and Research Institutes: Academic and Research Institutes use centrifuges for sample preparation, cell separation, protein analysis, and experimental research across life sciences and biotechnology programs.
The pharmaceutical and biotechnology companies segment is expected to grow at a CAGR of 7.7% during the forecast period, propelled by expanding biologics pipelines, higher research and development activity, and greater use of centrifugation in drug discovery, cell processing, and biomanufacturing. Others: Others include specialized users such as food testing laboratories, environmental testing facilities, and industrial research centers that require centrifugation for sample processing and material separation.
Speak to an Analystto discuss market opportunities.
The North America centrifuge market accounted for the largest regional share of 37.2% in 2025, supported by established pharmaceutical, biotechnology, food processing, and wastewater treatment industries. Strong laboratory infrastructure and continued investment in bioprocessing and industrial separation equipment provide a broad application base for centrifuge manufacturers across the region. The U.S. centrifuge market is supported by the EPA’s November 2025 announcement of $6.5 billion in WIFIA funding plus $550 million for states, providing substantial financing for water infrastructure projects and supporting future investment in wastewater treatment and related centrifuge equipment.
The Canada centrifuge market is supported by the Canadian government’s 2025 commitments of $49.9 million to STEMCELL Technologies’ $222 million biomanufacturing project and $60 million toward Delpharm’s $220 million facility expansion, strengthening domestic vaccine, therapeutics, and pharmaceutical manufacturing capacity and supporting demand for centrifugation equipment.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific centrifuge market is expected to grow at a CAGR of 8.2% during the forecast period, showcasing the fastest-growing regional market. The expansion of pharmaceutical manufacturing, food processing, biotechnology, wastewater treatment, and industrial production across countries such as China, India, Japan, and South Korea supports demand for centrifuge-based separation equipment. The China centrifuge market is supported by the latest biomedical development plan, which targets at least CNY 3.5 trillion in annual revenue from pharmaceutical enterprises above a designated size by 2030, supporting continued expansion of pharmaceutical manufacturing and related processing equipment demand.
The India centrifuge market is supported by the target of developing a USD 300 billion bioeconomy by 2030, compared with USD 165.7 billion in 2024, supporting future expansion of biomanufacturing and laboratory processing activities that use centrifugation.
The Japan centrifuge market is supported by the Ministry of Economy, Trade and Industry’s selection of 13 projects in 2025 under a manufacturing-equipment support program, with a total four-year government commitment of ¥38.3 billion for regenerative medicine, cell therapy, and gene therapy production facilities, supporting demand for advanced bioprocessing equipment.
The South Korea centrifuge market is supported by biohealth exports reaching a record USD 27.9 billion in 2025, while pharmaceutical exports surpassed USD 10.4 billion and biopharmaceutical exports reached USD 6.52 billion, supporting expansion of pharmaceutical and bioprocessing capacity.
The Europe centrifuge market is expected to grow at a CAGR of 6.5% during the forecast period, supported by established pharmaceutical, biotechnology, food processing, chemical, and wastewater-treatment industries. The region’s strong focus on process efficiency, product quality, and advanced laboratory infrastructure supports continued adoption of centrifuge-based separation equipment across industrial and research applications. The UK centrifuge market is supported by the UK Government’s 2025 Life Sciences Sector Plan, which targets more commercial life-sciences R&D investment than any other European economy by 2030, alongside up to £520 million in support for life-sciences manufacturing, creating a stronger future base for bioprocessing and centrifuge applications.
The Germany centrifuge market is supported by the €30 billion Deutschlandfonds launched in 2025, which is designed to mobilize around €130 billion in total investment, including financing for biotechnology, industrial production, and innovative technologies, supporting future investment across centrifuge-intensive applications.
The France centrifuge market is supported by the France 2030 program’s target of producing at least 20 biomedicines in France by 2030, supporting the expansion of domestic biopharmaceutical manufacturing and related separation processes.
The Middle East & Africa centrifuge market is expected to grow at a CAGR of 6.6% during the forecast period, supported by expanding healthcare, food processing, oil and gas, mining, and wastewater treatment activities. Investments in industrial processing and laboratory infrastructure across the region are creating broader applications for centrifuge-based separation, clarification, and dewatering equipment. The UAE centrifuge market is supported by Abu Dhabi’s launch of the HELM cluster in 2025 to develop an integrated biotechnology and pharmaceutical manufacturing ecosystem, while Sharjah announced three new pharmaceutical factories with combined investment exceeding AED 308.7 million, strengthening domestic pharmaceutical-processing capacity and supporting demand for centrifugation equipment.
The Africa centrifuge market is supported by the target of meeting at least 60% of the continent’s health-product needs through local manufacturing by 2040, while Africa CDC expects three African vaccine manufacturers to produce and obtain WHO prequalification for eight vaccines between 2025 and 2030, supporting future expansion of biomanufacturing and centrifuge-intensive processing.
The centrifuge market is moderately fragmented, with global laboratory-equipment manufacturers, clinical diagnostics companies, bioprocessing and industrial separation providers, and specialized regional centrifuge manufacturers competing across pharmaceutical, biotechnology, healthcare, food processing, chemical, mining, and wastewater applications. The leading players in the centrifuge market include Thermo Fisher Scientific, Eppendorf, Beckman Coulter, Sartorius AG, and Hettich Lab Technology.
Established players compete primarily through broad product portfolios, separation performance, automation, safety features, application expertise, global distribution networks, after-sales service, and compliance capabilities, while emerging players focus on cost-effective equipment, application-specific designs, compact systems, localized manufacturing, flexible customization, and responsive technical support to address specialized customer requirements and price-sensitive markets.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Organ Preservation Market Size, Share, Growth, Analysis, Report, 2034
Bacteriophage Market Size, Share, Growth, Analysis, 2034
Epigenetics Market Size, Share, Growth, Analysis, Report, 2034
Biobanking Market Size, Share, Growth, 2034
Cell Therapy Manufacturing Market Size, Share, Growth, 2034
Clinical Oncology Next Generation Sequencing Market Size, 2034
We are featured on:
sales@straitsresearch.com